EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”

Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)

DOI: 10.1155/omcl/9783010 ↗

Kurz gefasst

Korrektur in der Zeitschrift Oxidative Medicine and Cellular Longevity, online erschienen am 01.03.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”. Oxidative Medicine and Cellular Longevity, 2026(1). https://doi.org/10.1155/omcl/9783010

Vancouver

Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”. Oxidative Medicine and Cellular Longevity. 2026;2026(1). doi:10.1155/omcl/9783010

BibTeX
@article{euvimed2026,
  title = {Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/omcl/9783010}
}
Kostenlos starten →